Cranial Electrotherapy Stimulation and Acute Stress

September 3, 2025 updated by: Tufts University

Cranial Electrotherapy Stimulation (CES) Influences on Acute Stress Responses

The goal of this study is to quantify the effects of 20 sessions of Cranial Electrotherapy Stimulation (CES) on measures of acute stress responses in Soldiers. The main question it aims to answer is how 20 sessions of CES will affect Soldiers' biochemical (salivary alpha amylase and cortisol), physiological (e.g., heart rate, heart rate variability, respiration rate), emotional (state anxiety), and behavioral (i.e., cognitive task performance) responses.

  • On Day 1, participants will complete a baseline measure assessing their biochemical, physiological, emotional, and behavioral responses to a stressful lethal force decision making task.
  • In the next four to six weeks, participants will complete 20 CES sessions.
  • Within five days of completing the 20 CES sessions, participants will complete a follow-up measure assessing their biochemical, physiological, emotional, and behavioral responses to the same stressful lethal force decision making task they completed on Day 1.

Researchers will compare the Active CES group to the Sham CES group to see how 20 sessions of Active CES will affect the participants responses to their biochemical, physiological, emotional and behavioral responses relative to the Sham CES group.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

76

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Medford, Massachusetts, United States, 02155
        • Tufts University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18-40 years of age (17-40 if emancipated minor)
  • Can sit and stand freely.
  • Have not used or experienced CES administration in the past.
  • Agree to have their data stored in a repository (database) for future use.

Exclusion Criteria:

  • Use of prescription medications, other than oral contraceptives
  • Women only:

    1. Pregnant or plan to become pregnant during the study
    2. Nursing
  • History of:

    1. A neurological or psychological disorder (such as depression, anxiety disorders, migraines, cluster headaches, seizures, Post-traumatic stress disorder (PTSD) or panic attacks).
    2. Cardiac disease (including arrhythmia or fast or skipped heart beats).
    3. Implanted medical devices, such as pacemakers.
    4. Hypertension.
    5. Insomnia
    6. Head injury (including neurosurgery, concussion, TBI, skull fracture, hematoma)
    7. Illness that caused brain injury
    8. Any other brain-related condition (such as traumatic brain injury)
    9. Metal in the head (outside of mouth, such as shrapnel, surgical clips, or fragments from welding or metalwork)
    10. Implanted medical device (e.g., pacemaker, insulin pump)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Active CES
Active Cranial Electrotherapy Stimulation (CES)
Active CES group will receive a minimum of 250µA and up to 500µA depending on thresholding, once daily for 20 days (over the course of 4~6 weeks), 20 minutes per day.
Other Names:
  • Alpha-Stim
Sham Comparator: Sham CES
Sham Cranial Electrotherapy Stimulation (CES)
Sham CES group will be identical to Active CES group with the exception of the device not administering any electrical current
Other Names:
  • Alpha-Stim

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change From Baseline in Heart Rate During Stressful Lethal Force Decision Making Task
Time Frame: Baseline and follow-up session after 20 CES to be completed within 4-6weeks
heart rate will be measured in beats per minute.
Baseline and follow-up session after 20 CES to be completed within 4-6weeks
Change From Baseline in Respiration Rate During Stressful Lethal Force Decision Making Task
Time Frame: Baseline and follow-up session after 20 CES to be completed within 4-6weeks
respiration rate will be measured in breaths per minute.
Baseline and follow-up session after 20 CES to be completed within 4-6weeks
Change From Baseline in Heart Rate Variability During Stressful Lethal Force Decision Making Task
Time Frame: Baseline and follow-up session after 20 CES to be completed within 4-6weeks
Heart rate variability will be measured in RMSSD.
Baseline and follow-up session after 20 CES to be completed within 4-6weeks
Change Over Time in Cortisol During Stressful Lethal Force Decision Making Task
Time Frame: Baseline and follow-up session after 20 CES completed within 4-6weeks
Cortisol (µg/dL) will be measured through saliva samples. Saliva samples will be taken at five time points, approximately 20 minute increments during the baseline and follow-up sessions.
Baseline and follow-up session after 20 CES completed within 4-6weeks
Change Over Time in Alpha Amylase During Stressful Lethal Force Decision Making Task
Time Frame: Baseline and follow-up session after 20 CES completed within 4-6weeks
Alpha amylase (IU) will be measured through saliva samples. Saliva samples will be taken at five time points, approximately 20 minute increments during the baseline and follow-up sessions.
Baseline and follow-up session after 20 CES completed within 4-6weeks
Change Over Time in State Trait Anxiety Inventory (STAI) Scores at Each Session From Baseline to Follow-up
Time Frame: At baseline, at each of the 20 CES sessions completed within 4-6weeks, and at follow-up to be completed within 5 days of last CES
STAI assesses both state and trait anxiety separately with each scale ranging from 20 to 80, with higher scores correlating with greater anxiety. STAI-S is the State Trait Anxiety Inventory - State version, and STAI-T is the State Trait Anxiety Inventory - Trait version.
At baseline, at each of the 20 CES sessions completed within 4-6weeks, and at follow-up to be completed within 5 days of last CES
Change From Baseline in Recognition Memory
Time Frame: Baseline and follow-up session after 20 CES completed within 4-6weeks
Recognition memory of previously learned targets while ignoring visually similar distractor objects will be measured and evaluated with percent accuracy.
Baseline and follow-up session after 20 CES completed within 4-6weeks
Change From Baseline in Spatial Orientation
Time Frame: Baseline and follow-up session after 20 CES completed within 4-6weeks
Spatial orientation task will involve pointing towards a series of distant (out of visible range) landmarks in the virtual environment and estimating distance to those landmarks. Spatial orientation will be calculated using mean absolute angular error. Larger numbers correlate with higher error.
Baseline and follow-up session after 20 CES completed within 4-6weeks
Change From Baseline in Decision Making Accuracy
Time Frame: Baseline and follow-up session after 20 CES completed within 4-6weeks
Participants will make lethal force decision making by shooting at threatening targets and allowing non-threatening targets to pass. Decision making accuracy will be calculated using d prime. Higher d prime correlates with better accuracy.
Baseline and follow-up session after 20 CES completed within 4-6weeks
Change From Baseline in Decision Making Reaction Time
Time Frame: Baseline and follow-up session after 20 CES completed within 4-6weeks
Participants will make lethal force decision making by shooting at threatening targets and allowing non-threatening targets to pass. Decision making reaction time to shoot at threatening targets will be measured in milliseconds.
Baseline and follow-up session after 20 CES completed within 4-6weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kana Okano, Ph.D., Tufts University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 12, 2023

Primary Completion (Actual)

November 14, 2024

Study Completion (Actual)

November 14, 2024

Study Registration Dates

First Submitted

August 18, 2023

First Submitted That Met QC Criteria

September 5, 2023

First Posted (Actual)

September 13, 2023

Study Record Updates

Last Update Posted (Estimated)

September 15, 2025

Last Update Submitted That Met QC Criteria

September 3, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY00003572

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Participants consent to having their deidentified data placed in a repository/shared upon protocol closure, however it is not mandated by the protocol or institution.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe